logo
AI Icon𝛼SK or Search
bullish

China Biotech/Pharma Sector: 1H26 Results Wrap and Pipeline Catalyst Table

112 Views03 Sep 2026 13:04
We track 36 major commercial-stage biotech/pharma companies in China for key takeaways/readthroughs and updated sector's major pipeline catalysts eg. upcoming ESMO for sac-TMT, SMMT/Akeso: Harmoni-2
What is covered in the Full Insight:
  • Introduction
  • 1H26 Key Trends
  • Innovent Biologics Performance
  • Hengrui's Results and Challenges
  • Upcoming Catalysts and Expectations
Logo
Wilfred Yuen
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x